{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:30:45Z","timestamp":1785684645685,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":832,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"N. Allen and Barbara B. Kannapell Fund for Melanoma Oncology Research"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41379-020-0565-5","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T08:06:45Z","timestamp":1589357205000},"page":"2067-2074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["TERT amplification but not activation of canonical Wnt\/\u03b2-catenin pathway is involved in acral lentiginous melanoma progression to metastasis"],"prefix":"10.1016","volume":"33","author":[{"given":"Nisha S.","family":"Ramani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-0573","authenticated-orcid":false,"given":"Phyu P.","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sfamenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sdringola-Maranga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5346-2669","authenticated-orcid":false,"given":"Priyardhisini","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doina","family":"Ivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jen","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7422-0661","authenticated-orcid":false,"given":"Carlos A.","family":"Torres-Cabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0565-5_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","article-title":"Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005","volume":"145","author":"Bradford","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib2","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1016\/j.jaad.2011.05.030","article-title":"Melanoma survival in the United States, 1992 to 2005","volume":"65","author":"Pollack","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-319-22539-5_14","article-title":"Acral lentiginous melanoma","volume":"167","author":"Goydos","year":"2016","journal-title":"Cancer Treat Res."},{"key":"10.1038\/s41379-020-0565-5_bib4","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1245\/s10434-013-3089-0","article-title":"Prognosis of acral melanoma: a series of 281 patients","volume":"20","author":"Bello","year":"2013","journal-title":"Ann Surg Oncol."},{"key":"10.1038\/s41379-020-0565-5_bib5","doi-asserted-by":"crossref","unstructured":"Pradhan D, Jour G, Milton D,Vasudevaraja V, Tetzlaff MT, Nagarajan P, et al. Aberrant DNA methylation predicts melanoma-specific survival in patients with acral melanoma. Cancers (Basel). 2019;11.","DOI":"10.3390\/cancers11122031"},{"key":"10.1038\/s41379-020-0565-5_bib6","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/1346-8138.14805","article-title":"Efficacy of combined radiotherapy and anti-programmed death 1 therapy in acral and mucosal melanoma","volume":"46","author":"Kato","year":"2019","journal-title":"J Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11864-018-0560-y","article-title":"Diagnosis and management of acral lentiginous melanoma","volume":"19","author":"Nakamura","year":"2018","journal-title":"Curr Treat Options Oncol."},{"key":"10.1038\/s41379-020-0565-5_bib8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/CMR.0000000000000222","article-title":"Molecular profiling, including TERT promoter mutations, of acral lentiginous melanomas","volume":"26","author":"Vazquez Vde","year":"2016","journal-title":"Melanoma Res."},{"key":"10.1038\/s41379-020-0565-5_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jid.2017.11.017","article-title":"Genetic alterations in primary acral melanoma and acral melanocytic nevus in Korea: common mutated genes show distinct cytomorphological features","volume":"138","author":"Moon","year":"2018","journal-title":"J Investig Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib10","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/modpathol.2009.116","article-title":"Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous\/mucosal type","volume":"22","author":"Torres-Cabala","year":"2009","journal-title":"Mod Pathol."},{"key":"10.1038\/s41379-020-0565-5_bib11","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med."},{"key":"10.1038\/s41379-020-0565-5_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/cup.12323","article-title":"TERT promoter mutation is uncommon in acral lentiginous melanoma","volume":"41","author":"Liau","year":"2014","journal-title":"J Cutan Pathol."},{"key":"10.1038\/s41379-020-0565-5_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep45704","article-title":"Genetic and epigenetic alterations of TERT are associated with inferior outcome in adolescent and young adult patients with melanoma","volume":"7","author":"Seynnaeve","year":"2017","journal-title":"Sci Rep."},{"key":"10.1038\/s41379-020-0565-5_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmoldx.2013.10.009","article-title":"TERT and AURKA gene copy number gains enhance the detection of acral lentiginous melanomas by fluorescence in situ hybridization","volume":"16","author":"Diaz","year":"2014","journal-title":"J Mol Diagn."},{"key":"10.1038\/s41379-020-0565-5_bib15","doi-asserted-by":"crossref","unstructured":"Griewank KG, Murali R, Puig-Butille JA, Schilling B, Livingstone E, Potrony M, et al. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma. J Natl Cancer Inst. 2014;106.","DOI":"10.1093\/jnci\/dju246"},{"key":"10.1038\/s41379-020-0565-5_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/DAD.0000000000001259","article-title":"Utility of TERT promoter mutations for cutaneous primary melanoma diagnosis","volume":"41","author":"Thomas","year":"2019","journal-title":"Am J Dermatopathol."},{"key":"10.1038\/s41379-020-0565-5_bib17","doi-asserted-by":"crossref","first-page":"10048","DOI":"10.18632\/oncotarget.2491","article-title":"TERT promoter mutations and gene amplification: promoting TERT expression in Merkel cell carcinoma","volume":"5","author":"Xie","year":"2014","journal-title":"Oncotarget."},{"key":"10.1038\/s41379-020-0565-5_bib18","doi-asserted-by":"crossref","unstructured":"Gaspar TB, Sa A, Lopes JM, Sobrinho-Sim\u00f5es M, Soares P, Vinagre J. Telomere maintenance mechanisms in cancer. Genes. 2018;9.","DOI":"10.3390\/genes9050241"},{"key":"10.1038\/s41379-020-0565-5_bib19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/sj.bjc.6603110","article-title":"Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer","volume":"94","author":"Zhu","year":"2006","journal-title":"Br J Cancer."},{"key":"10.1038\/s41379-020-0565-5_bib20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/ng.3438","article-title":"TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors","volume":"47","author":"Valentijn","year":"2015","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0565-5_bib21","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jaad.2014.05.035","article-title":"TERT gene amplification is associated with poor outcome in acral lentiginous melanoma","volume":"71","author":"Diaz","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib22","doi-asserted-by":"crossref","unstructured":"Motaparthi K, Kim J, Andea AA, Missall TA, Novoa RA, Vidal CI, et al. TERT and TERT promoter in melanocytic neoplasms: current concepts in pathogenesis, diagnosis, and prognosis. J Cutan Pathol. 2020. https:\/\/doi.org\/10.1111\/cup.13691. [Epub ahead of print]","DOI":"10.1111\/cup.13691"},{"key":"10.1038\/s41379-020-0565-5_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00432-016-2322-1","article-title":"Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients","volume":"143","author":"Ofner","year":"2017","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1038\/s41379-020-0565-5_bib24","first-page":"1389","article-title":"Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment","volume":"7","author":"Santiago","year":"2017","journal-title":"Am J Cancer Res."},{"key":"10.1038\/s41379-020-0565-5_bib25","first-page":"139268","article-title":"General aspects of colorectal cancer","volume":"2012","author":"Centelles","year":"2012","journal-title":"ISRN Oncol."},{"key":"10.1038\/s41379-020-0565-5_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/dna.2014.2590","article-title":"Increased levels of beta-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2","volume":"34","author":"Xu","year":"2015","journal-title":"DNA Cell Biol."},{"key":"10.1038\/s41379-020-0565-5_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejca.2019.06.011","article-title":"Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma","volume":"119","author":"Kanaki","year":"2019","journal-title":"Eur J Cancer."},{"key":"10.1038\/s41379-020-0565-5_bib28","doi-asserted-by":"crossref","unstructured":"Dantonio PM, Klein MO, Freire M, Araujo CN, Chiacetti AC, Correa RG. Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy. Biosci Rep. 2018;38.","DOI":"10.1042\/BSR20180511"},{"key":"10.1038\/s41379-020-0565-5_bib29","doi-asserted-by":"crossref","first-page":"e0177126","DOI":"10.1371\/journal.pone.0177126","article-title":"Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan","volume":"12","author":"Sheen","year":"2017","journal-title":"PLoS One."},{"key":"10.1038\/s41379-020-0565-5_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/exd.12080","article-title":"Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma","volume":"22","author":"Puig-Butille","year":"2013","journal-title":"Exp Dermatol."},{"key":"10.1038\/s41379-020-0565-5_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng.3781","article-title":"Systematic analysis of telomere length and somatic alterations in 31 cancer types","volume":"49","author":"Barthel","year":"2017","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0565-5_bib32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/ng.3382","article-title":"Exome sequencing of desmoplastic melanoma identifies recurrent NFKBIE promoter mutations and diverse activating mutations in the MAPK pathway","volume":"47","author":"Shain","year":"2015","journal-title":"Nat Genet."},{"key":"10.1038\/s41379-020-0565-5_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/pcmr.12471","article-title":"Association of TERT promoter mutations with telomerase expression in melanoma","volume":"29","author":"Lee","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1038\/s41379-020-0565-5_bib34","doi-asserted-by":"crossref","first-page":"016008","DOI":"10.1088\/1478-3975\/12\/1\/016008","article-title":"Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients","volume":"12","author":"Ruiz","year":"2015","journal-title":"Phys Biol."},{"key":"10.1038\/s41379-020-0565-5_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bjc.2017.384","article-title":"Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma","volume":"118","author":"Hugdahl","year":"2018","journal-title":"Br J Cancer."},{"key":"10.1038\/s41379-020-0565-5_bib36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.humpath.2018.08.002","article-title":"Concordance of somatic mutation profiles (BRAF,NRAS, and TERT) and tumoral PD-L1 in matched primary cutaneous and metastatic melanoma samples","volume":"82","author":"Yang","year":"2018","journal-title":"Hum Pathol."},{"key":"10.1038\/s41379-020-0565-5_bib37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1101\/gr.213348.116","article-title":"Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma","volume":"27","author":"Liang","year":"2017","journal-title":"Genome Res."},{"key":"10.1038\/s41379-020-0565-5_bib38","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1038\/s41388-018-0247-7","article-title":"Exploiting TERT dependency as a therapeutic strategy for NRAS-mutant melanoma","volume":"37","author":"Reyes-Uribe","year":"2018","journal-title":"Oncogene."}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0565-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222004768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:36:46Z","timestamp":1760229406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222004768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0893395222004768"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0565-5","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TERT amplification but not activation of canonical Wnt\/\u03b2-catenin pathway is involved in acral lentiginous melanoma progression to metastasis","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0565-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}